Corrado Castellucci
Directeur Général chez Recordati Rare Diseases Germany GmbH
Profil
Corrado Castellucci is currently the Chairman at Recordati Orphan Drugs SAS, Co-Managing Director at Recordati Rare Diseases Germany GmbH, Director at Recordati Rare Diseases UK Ltd., and Member-Supervisory Board at Recordati AG.
He previously held positions as Chief Executive Officer at Gilead Sciences Srl, Director-Specialty Care Division at AstraZeneca SpA, Executive VP-Rare Diseases Business Unit at Recordati SpA, and General Manager at Adienne SRL.
Postes actifs de Corrado Castellucci
| Sociétés | Poste | Début |
|---|---|---|
Recordati Rare Diseases Germany GmbH
 Recordati Rare Diseases Germany GmbH Medical DistributorsDistribution Services Recordati Rare Diseases Germany GmbH is a pharmaceutical wholesaler based in Germany. The German company's main focus is on distributing pharmaceutical products. | Directeur Général | - |
Recordati Rare Diseases UK Ltd.
 Recordati Rare Diseases UK Ltd. Medical DistributorsDistribution Services Founded in 1996, Recordati Rare Diseases UK Ltd. is a pharmaceutical company that sells pharmaceutical products. The company is based in Maidenhead, UK and is part of CVC Advisers Ltd. | Directeur/Membre du Conseil | 07/05/2013 |
Recordati AG
 Recordati AG Drugstore ChainsRetail Trade Recordati AG engages in the trading in as well as importation and exportation of pharmaceutical, biological, chemical, laboratory, and diagnostic products. It also provides consulting services in the areas of marketing and management, with focus on the pharmaceutical industry. The company was founded on June 8, 2011 and is headquartered in Baar, Switzerland. | Directeur/Membre du Conseil | - |
Recordati Orphan Drugs SAS
 Recordati Orphan Drugs SAS Financial ConglomeratesFinance Part of CVC Advisers Ltd., Recordati Orphan Drugs SAS is a French company that functions as an investment holding company. The company is based in Puteaux, France. The company was founded in 2007. Scott Pescatore has been the CEO of the company since 2020. | Président | 12/06/2013 |
Anciens postes connus de Corrado Castellucci
| Sociétés | Poste | Fin |
|---|---|---|
Adienne SRL
 Adienne SRL Pharmaceuticals: MajorHealth Technology Adienne SRL manufactures pharmaceutical products. It offers drug products for oncohematology, autoimmune diseases, and bone marrow transplantation. The company was founded in 2004 and is headquartered in Caponago, Italy. | Directeur Général | - |
AstraZeneca SpA
 AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Corporate Officer/Principal | - |
Gilead Sciences Srl
 Gilead Sciences Srl Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., Gilead Sciences Srl is a research-based biopharmaceutical company based in Milan, Italy. The Italian company's focus is on the discovery, development, and commercialization of innovative medicines. The company's pipeline includes investigational medicines with the potential to help advance care in HIV, viral hepatitis, cancer, and inflammation. | Directeur Général | - |
| RECORDATI | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RECORDATI | Health Technology |
| Entreprise privées | 7 |
|---|---|
AstraZeneca SpA
AstraZeneca SpA Pharmaceuticals: MajorHealth Technology AstraZeneca SpA engages in the production and distribution of pharmaceutical drugs and medicines. Its products specialize in the treatment and therapies for cardiovascular and metabolic, oncology, and respiratory inflammation, and autoimmunity diseases. The company was founded in April 1999 is headquartered in Basiglio, Italy. | Health Technology |
Gilead Sciences Srl
Gilead Sciences Srl Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., Gilead Sciences Srl is a research-based biopharmaceutical company based in Milan, Italy. The Italian company's focus is on the discovery, development, and commercialization of innovative medicines. The company's pipeline includes investigational medicines with the potential to help advance care in HIV, viral hepatitis, cancer, and inflammation. | Health Technology |
Adienne SRL
Adienne SRL Pharmaceuticals: MajorHealth Technology Adienne SRL manufactures pharmaceutical products. It offers drug products for oncohematology, autoimmune diseases, and bone marrow transplantation. The company was founded in 2004 and is headquartered in Caponago, Italy. | Health Technology |
Recordati Rare Diseases Germany GmbH
Recordati Rare Diseases Germany GmbH Medical DistributorsDistribution Services Recordati Rare Diseases Germany GmbH is a pharmaceutical wholesaler based in Germany. The German company's main focus is on distributing pharmaceutical products. | Distribution Services |
Recordati Rare Diseases UK Ltd.
Recordati Rare Diseases UK Ltd. Medical DistributorsDistribution Services Founded in 1996, Recordati Rare Diseases UK Ltd. is a pharmaceutical company that sells pharmaceutical products. The company is based in Maidenhead, UK and is part of CVC Advisers Ltd. | Distribution Services |
Recordati AG
Recordati AG Drugstore ChainsRetail Trade Recordati AG engages in the trading in as well as importation and exportation of pharmaceutical, biological, chemical, laboratory, and diagnostic products. It also provides consulting services in the areas of marketing and management, with focus on the pharmaceutical industry. The company was founded on June 8, 2011 and is headquartered in Baar, Switzerland. | Retail Trade |
Recordati Orphan Drugs SAS
Recordati Orphan Drugs SAS Financial ConglomeratesFinance Part of CVC Advisers Ltd., Recordati Orphan Drugs SAS is a French company that functions as an investment holding company. The company is based in Puteaux, France. The company was founded in 2007. Scott Pescatore has been the CEO of the company since 2020. | Finance |
